Do you perform a bone health assessment in men who will be receiving short term androgen deprivation for localized prostate cancer?
If so, does it differ from the assessment you would perform in men receiving long term ADT?
Answer from: Radiation Oncologist at Academic Institution
I do not order bone densitometry on patients I am treating with short term (<= 6 months) of AD, unless they have a risk factor like long-term glucocorticoid use or prior fracture. For patients I am treating with long term >=18 months I perform a baseline bone densitometry. If that ...